Abstract
Mycobacterium tuberculosis is a killer bacteria endangering the life of many innocent people worldwide. There is an emergency need for newer TB vaccines to combat this deadly disease. The BCG vaccine currently being delivered has been in use for more than a decade but still the threat has been increasing day-by-day worldwide and more particularly among the developing nations. It is necessary to develop a candidate vaccines which can keep a check on the primary progression of the disease and also reactivation of Latent TB Infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
